GARY L POSTELWAIT
Allopathic & Osteopathic Physicians|Internal Medicine TULSA, OK NPI 1972523934
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine OK Novo Nordisk AS All categories
General Payments — all program years on this page
$2,090.28
- Category: General Payments
- Program years: PY2018–2020
- Record count: 148
- As of (CMS publication): 2026-01-23
Latest program year (PY2020): $119.92 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2020) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $119.92 | 7 |
By paying entity
Latest program year (PY2020) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $38.29 | 2 |
| Mylan Specialty L.P. | $21.56 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.20 | 1 |
| PFIZER INC. | $16.90 | 1 |
| Acerta Pharma LLC | $14.58 | 1 |
| Janssen Pharmaceuticals, Inc | $11.39 | 1 |
By program year
Records — PY2020 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 719146857 | Janssen Pharmaceuticals, Inc | $11.39 | 03/04/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 735798537 | AstraZeneca Pharmaceuticals LP | $14.58 | 01/14/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 743704937 | PFIZER INC. | $16.90 | 01/27/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 744604871 | Novo Nordisk Inc | $19.97 | 02/17/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 744730913 | Novo Nordisk Inc | $18.32 | 03/11/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 747283323 | Takeda Pharmaceuticals U.S.A., Inc. | $17.20 | 02/21/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 751383509 | Mylan Specialty L.P. | $21.56 | 02/07/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.